IFNG and neoplasm: In contrast, tumour-derived IFNγ transcriptomic signatures demonstrate superior predictive performance in on-treatment samples [26], with greater induction of IFNγ response genes, particularly antigen presentation genes, in responders following ICI therapy [25].